Current Issue Subscriptions
Back Issues Advertising
More Information Classified Ads
For Authors Continuing Education
Vol. 74, No. 6
ISSN: 1488-2159
July / August 2008


Bisphosphonates, Osteonecrosis, Osteogenesis Imperfecta and Dental Extractions: A Case Series


Correction: The first sentence of the Conclusion on p. 541 has been modified.
Corrected web version posted October 9, 2008, at 12:00 EST.

• Stephane Schwartz, DDS, MSD, FRCD(C) •
• Clara Joseph, DMD, MSc •
• Deborah Iera, DDS, FRCD(C) •
• Duy-Dat Vu, DMD, MSc, FRCD(C) •

A b s t r a c t

Over the past 4 years, numerous cases of osteonecrosis of the jaw in patients treated with bisphosphonates have been reported. Since 1998, children and adolescents with osteogenesis imperfecta have received bisphosphonates to increase their bone density and reduce the incidence of bone fractures. The results have been convincing, but recent reports of osteonecrosis of the jaw have caused great concern when these patients require dental extractions. The dental records of 15 children and adolescents with osteogenesis imperfecta, involving 60 dental extractions, mostly of primary teeth, done between 2001 and 2006, were reviewed. All patients but one had had or were having bisphosphonate treatment at the time of the extractions. No patient developed osteonecrosis. Further studies and data that allow clinicians to design adequate and safe treatment plans for this unique population are needed.


Reply to this article | View replies [0]

Full text provided in PDF format


Mission Statement & Editor's Message | Multimedia Centre | Readership Survey
Contact the Editor | Fran็ais